EUVIMEDScopri EUVIMED
Crossref

Impact of treatment of subclinical rejection at 2 weeks after kidney transplantation, compared by analysis of 1-year histologic outcomes

Okjoo Lee, Kyo Won Lee, Jae Berm Park, Jung Eun Lee, Na Young Hwang, Kyunga Kim

Korean Journal of Transplantation · 2020

DOI: 10.4285/atw2020.op-1102 ↗

At a glance

Journal article in Korean Journal of Transplantation, 2020. Written by Okjoo Lee and 5 co-authors.

AbstractDati bibliograficiCiteRelated studies

Abstract (original language)

Background

Subclinical rejection (SCR) is associated with chronic allograft nephropathy, which is the most common cause of allograft failure in kidney transplantation (KT). Therefore, early detection and treatment of SCR through protocol biopsy can reduces the incidence of chronic allograft nephropathy and the improvement of graft survival. This study aims to evaluate the effective early detection role of routine protocol biopsy by comparing the pathologic outcome.

Methods

We retrospectively analyzed 914 KT recipients in Samsung Medical Center between August 2012 and December 2018. Of these, pediatric cases, re-transplantations and multi-organ transplantation, cyclosporine and azathioprine users, patients who were not underwent protocol biopsy, and diagnosed rejection but not treated patients were excluded. Finally, a total of 624 adult patients who were underwent protocol biopsy at post KT 2 weeks and 1 year were analyzed.

Results

After propensity score matching, patients were divided into two groups, 2-week protocol biopsy proven normal group (n=256) and rejection group (n=96). Before propensity matching, normal group was significant higher recipient age and ABO incompatible KT, rejection group was higher human leukocyte antigen II mismatch and proportion of deceased donor KT, the difference was corrected through matching. Rejection group showed no significant difference from normal group in the tendency of graft function (estimated glomerular filtration rate), and Kaplan-Meier curve also shown that in graft survival. In the pathologic outcomes between two groups and two periods, the pathological differences between two groups showed a decrease between two periods.

Conclusions

SCR treatment through protocol biopsy can contribute to maintenance of graft function and improvement of pathologic change.

Cite

APA

Lee, O., Lee, K. W., Park, J. B., Lee, J. E., Hwang, N. Y., & Kim, K. (2020). Impact of treatment of subclinical rejection at 2 weeks after kidney transplantation, compared by analysis of 1-year histologic outcomes. Korean Journal of Transplantation. https://doi.org/10.4285/atw2020.op-1102

Vancouver

Lee O, Lee KW, Park JB, Lee JE, Hwang NY, Kim K. Impact of treatment of subclinical rejection at 2 weeks after kidney transplantation, compared by analysis of 1-year histologic outcomes. Korean Journal of Transplantation. 2020. doi:10.4285/atw2020.op-1102

BibTeX
@article{Lee2020,
  author = {Lee, Okjoo and Lee, Kyo Won and Park, Jae Berm and Lee, Jung Eun and Hwang, Na Young and Kim, Kyunga},
  title = {Impact of treatment of subclinical rejection at 2 weeks after kidney transplantation, compared by analysis of 1-year histologic outcomes},
  journal = {Korean Journal of Transplantation},
  year = {2020},
  doi = {10.4285/atw2020.op-1102}
}
Start for free →